3D Medicines Launches Up to $55 Million Hong Kong IPO?

3D Medicines Launches Up to $55 Million Hong Kong IPO?

WebDec 15, 2024 · Dec. 15, 2024. By Doris Yu. 3D Medicines Inc. has raised HK$408 million (US$52.5 million) in a listing on the Hong Kong Stock Exchange. Its shares opened at HK$29 apiece, jumped by more than 20% by the middle of the day, and closed at HK$31.45 on the first trading day of Dec. 15. BioWorld Financings Public IPO Asia-Pacific China. action iteration in uft WebNov 24, 2024 · 3D Medicines Inc. 3D Medicines Inc. is a Hong Kong company, incorporated on Monday - June 07, 2024, as of today, the company has been operating … WebMar 10, 2024 · 3D MEDICINES INC. (HKG:1244) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share 3D MEDICINES INC. Hong Kong Stock … archaea metabolism WebJul 15, 2024 · 3D Medicines has 2 employees across 4 locations and $281 m in total funding,. See insights on 3D Medicines including office locations, competitors, revenue, … WebOn 26 November 2024, 3D Medicines (Beijing) Co., Ltd. (3DMed) , Alphamab Oncology (stock code: 9966.HK),and Simcere Pharmaceutical Group Limited (Simcere) jointly announced that Envafolimab ... archaea metabolismo Web思路迪醫藥科技(香港)有限公司 3D Medicines (Hong Kong) Co., Limited 成立於2024年02月08日。公司註冊編號是:2654036,公司類別屬於私人股份有限公司 ,截至今日, …

Post Opinion